Stanley Frankel

Director/Board Member at PRECISION BIOSCIENCES, INC.

Net worth: 282 132 $ as of 2026-05-30

67 year

Health Technology

Consumer Services

Profile

Stanley R.
Frankel is an Independent Non-Executive Director at Precision BioSciences, Inc. since 2021.
Dr. Frankel is an Independent Director at CREATE Medicines, Inc. (Massachusetts) since 2022.
Formerly, Dr. Frankel was SVP-Global Drug Development & Cellular Therapy at Bristol Myers Squibb Co. from 2019 to 2020.
Dr. Frankel was VP, Head-Clinical Research & Development at Celgene Corp.
from 2015 to 2019.
Dr. Frankel was Chief Medical Officer at Cytovia Therapeutics, Inc. Education includes a doctorate from Northwestern University and an undergraduate degree from Harvard College.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
PRECISION BIOSCIENCES, INC. 0.17%	2026-06-02	40,478 ( 0.17% )	282 132 $	2026-05-30

Stanley Frankel active positions

Companies	Position	Start
PRECISION BIOSCIENCES, INC.	Director/Board Member	2021-04-11
Myeloid Therapeutics, Inc. Myeloid Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic drugs for the treatment of tumors and autoimmune diseases	Director/Board Member	2022-06-29

All active positions of Stanley Frankel

Former positions of Stanley Frankel

Companies	Position	End
BRISTOL-MYERS SQUIBB COMPANY	Corporate Officer/Principal	2020-09-30
CELGENE	Chief Tech/Sci/R&D Officer	2019-10-31
Cytovia Therapeutics, Inc. Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies for cancer and infectious diseases	Chief Tech/Sci/R&D Officer	-

See the detail of Stanley Frankel's experience

Training of Stanley Frankel

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Stanley Frankel's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	7
Bristol Myers Squibb Co. Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products	Health Technology
Celgene Corp. Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs	Health Technology
Precision BioSciences, Inc. Precision BioSciences, Inc. BiotechnologyHealth Technology Develops technology to produce custom, genome-editing enzymes for human health and biological research	Health Technology
Northwestern University Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Harvard College Harvard College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Myeloid Therapeutics, Inc. Myeloid Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic drugs for the treatment of tumors and autoimmune diseases	Health Technology
Cytovia Therapeutics, Inc. Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies for cancer and infectious diseases	Health Technology